pubrio
GenEditBio Limited

GenEditBio Limited

Hong Kong · Biotechnology Research

Pharmaceuticals

Biotechnology

Healthcare

Biotechnology Research

Established in 2021 and headquartered in Hong Kong, China, GenEditBio is a gene therapy start-up company with an overarching strategic goal of providing potentially curative, once-and-done and programmable in vivo genome editing-based therapeutic solutions (dubbed “DNA surgery”) with high safety profile, unmatched precision, and affordable access for genetic diseases with unmet needs. The Company’s core areas of focus include novel Cas nuclease discovery and safe and efficient cargo delivery utilizing lipid nanoparticle (LNP) and engineered protein delivery vehicle (PDV). We have research laboratories and supporting offices in Hong Kong, Beijing, and Boston.

Company Insights
Company Overview

2021

Founded

Biotechnology Research

Industry

Hong Kong

Location

14,996,360

Ranking

20 employees

Size

Similar Companies

Get full access to view complete information

Frequently Asked Questions Regarding GenEditBio Limited

Start your journey today

Start with the platform — or start with a conversation

Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.

pubrio

Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.​